| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $567.8M | -38.2% |
| Cost of Revenue | $525.8M | -37.9% |
| Gross Profit | $42.0M | -41.8% |
| R&D Expense | $3.4M | -24.7% |
| SG&A Expense | $26.2M | -35.5% |
| Operating Income | -$33.4M | +27.5% |
| Pre-tax Income | -$45.9M | +26.1% |
| Income Tax | $441K | +1322.6% |
| Net Income | -$46.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.5M | -38.3% |
| Accounts Receivable | $7.9M | +106.3% |
| Inventory | $93.8M | -56.2% |
| Current Assets | $131.7M | -55.2% |
| Total Assets | $154.8M | -50.6% |
| Current Liabilities | $88.8M | -64.6% |
| Total Liabilities | $116.6M | -56.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.8M | +220.7% |
| Capital Expenditures | $1.1M | -80.0% |
| Investing Cash Flow | -$1.1M | +80.1% |
| Financing Cash Flow | -$111.2M | -409.8% |
| Free Cash Flow | $65.7M | +326.1% |
| +25.4% |
| EPS (Basic) | -$1.50 | +33.9% |
| EPS (Diluted) | -$1.50 | +33.9% |
| Stockholders' Equity |
| $38.2M |
| -19.8% |